| For: | Shi YJ, Dong GJ, Guo M. Targeting epicardial adipose tissue: A potential therapeutic strategy for heart failure with preserved ejection fraction with type 2 diabetes mellitus. World J Diabetes 2023; 14(6): 724-740 [PMID: 37383601 DOI: 10.4239/wjd.v14.i6.724] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v14/i6/724.htm |
| Number | Citing Articles |
| 1 |
Tian-Yu Wang, Qiang Yang, Xin-Yi Cheng, Jun-Can Ding, Peng-Fei Hu. Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction. Heart Failure Reviews 2024; 30(1): 17 doi: 10.1007/s10741-024-10438-2
|
| 2 |
Jacob Whitman, Elie Kozaily, Erin D. Michos, Daniel N. Silverman, Marat Fudim, Robert J. Mentz, Ryan J. Tedford, Vishal N. Rao. Epicardial Fat in Heart Failure and Preserved Ejection Fraction: Novel Insights and Future Perspectives. Current Heart Failure Reports 2025; 22(1) doi: 10.1007/s11897-025-00700-5
|
| 3 |
Nassiba Menghoum, Maria Chiara Badii, Martin Leroy, Marie Parra, Clotilde Roy, Sibille Lejeune, David Vancraeynest, Agnes Pasquet, Dulce Brito, Barbara Casadei, Christophe Depoix, Gerasimos Filippatos, Damien Gruson, Frank Edelmann, Vanessa M. Ferreira, Renaud Lhommel, Masliza Mahmod, Stefan Neubauer, Alexandre Persu, Stefan Piechnik, Kristian Hellenkamp, Ignatios Ikonomidis, Bartosz Krakowiak, Burkert Pieske, Elisabeth Pieske-Kraigher, Fausto Pinto, Piotr Ponikowski, Michele Senni, Jean-Noël Trochu, Nancy Van Overstraeten, Rolf Wachter, Bernhard L. Gerber, Jean-Luc Balligand, Christophe Beauloye, Anne-Catherine Pouleur. Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction. Cardiovascular Diabetology 2025; 24(1) doi: 10.1186/s12933-025-02688-7
|
| 4 |
Zhongwen Qi, Dan Wu, Zhipeng Yan, Qing Wang, Yiming Li, Junnan Zhao, Fengqin Xu. Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential. Obesity Reviews 2025; 26(7) doi: 10.1111/obr.13912
|
| 5 |
Ruijue Huang, Wenjia Li, Zhen Xie, Kaimin Zhuo, Jing Zhu. Epicardial Adipose Tissue and Major Adverse Cardiovascular Events in Myocardial Infarction Patients with and without Diabetes. Academic Radiology 2024; 31(9): 3546 doi: 10.1016/j.acra.2024.04.001
|
| 6 |
Xiangling Duan, Xiaomeng Zhang, Bao Sun. The landscape of novel antidiabetic drugs in diabetic HFpEF: relevant mechanisms and clinical implications. Cardiovascular Diabetology 2025; 24(1) doi: 10.1186/s12933-025-02750-4
|
| 7 |
Shaun Khanna, Gurkeerat Mann, Sheran Vasanthakumar, Clare Arnott, Nitesh Nerlekar. From Cushion to Culprit: The Role of Epicardial Adipose Tissue in Cardiovascular Disease. Heart, Lung and Circulation 2025; 34(10): 1006 doi: 10.1016/j.hlc.2025.07.010
|
| 8 |
Wenwen Zheng, Qianxian Qi, Jie Li, Chaojie He, Hongyan Fan. Heart failure with preserved ejection fraction and obesity: emerging metabolic therapeutic strategies. Diabetology & Metabolic Syndrome 2025; 17(1) doi: 10.1186/s13098-025-01917-z
|
| 9 |
Paolo Raggi, Arthur E. Stillman. Clinical Role of Epicardial Adipose Tissue. Canadian Journal of Cardiology 2025; 41(9): 1753 doi: 10.1016/j.cjca.2025.02.021
|
| 10 |
Lingyun Luo, Yuyue Zuo, Lei Dai. Metabolic rewiring and inter-organ crosstalk in diabetic HFpEF. Cardiovascular Diabetology 2025; 24(1) doi: 10.1186/s12933-025-02707-7
|
| 11 |
Zhicheng Liu, Jiayun Zhang, Tingzhou Hou, Yingxiang Song. A review of the relationship between epicardial adipose tissue and cerebral white matter microstructural damage in type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2025; 227: 112384 doi: 10.1016/j.diabres.2025.112384
|
| 12 |
Jeehyun Kim, Gwang Hyeon Eom, Somy Yoon. Heart failure with preserved ejection fraction: current insights and emerging therapeutic directions. The Korean Journal of Physiology & Pharmacology 2026; 30(3): 169 doi: 10.4196/kjpp.25.250
|
| 13 |
Lilian Anagnostopoulou, Nikolaos Ktenopoulos, Anastasios Apostolos, Christos Fragoulis, Panayotis Vlachakis, Paschalis Karakasis, Marios Sagris, Nikias Milaras, Maria Drakopoulou, Andreas Synetos, Ioannis Kyriazis, Ioannis Ioannidis, Costas Tsioufis, Konstantinos Toutouzas. Intersecting Molecular Pathways in Cardiovascular Disease and Diabetes Mellitus: Emerging Roles of Inflammation and Therapeutics. Diabetes/Metabolism Research and Reviews 2026; 42(4) doi: 10.1002/dmrr.70167
|
| 14 |
Marius-Dragoș Mihăilă, Bogdan Caloian, Florina Iulia Frîngu, Diana Andrada Irimie, Ioan Alexandru Minciună, Dana Pop. Beyond Traditional Risk Factors: Integrating Epicardial Adipose Tissue into the Comorbidity Landscape of HFpEF. Journal of Clinical Medicine 2025; 14(17): 6139 doi: 10.3390/jcm14176139
|
| 15 |
Qiuxuan Li, Ur Rehman Muhib, Xiaoteng Ma, Zaiqiang Liu, Fei Gao, Zhijian Wang. Potential Mechanisms of Epicardial Adipose Tissue Influencing Heart Failure with Preserved Ejection Fraction. Reviews in Cardiovascular Medicine 2024; 25(9) doi: 10.31083/j.rcm2509311
|
| 16 |
Aml Mohamed Soliman, Ramadan Ghaleb, Amr H. Mahmoud, Mustafa Al-Hassan Abdou Heidar, Ayman Ibrahim. Targeting epicardial adipose tissue in heart failure with preserved ejection fraction: exploring the dapagliflozin connection. BMC Cardiovascular Disorders 2026; 26(1) doi: 10.1186/s12872-026-05819-4
|
| 17 |
Yuanwei Xu, Jiajun Guo, Yangjie Li, Shiqian Wang, Ke Wan, Weihao Li, Jie Wang, Ziqian Xu, Wei Cheng, Jiayu Sun, Qing Zhang, Yuchi Han, Yucheng Chen. Increased epicardial adipose tissue is associated with left ventricular reverse remodeling in dilated cardiomyopathy. Cardiovascular Diabetology 2024; 23(1) doi: 10.1186/s12933-024-02517-3
|
| 18 |
Martina Vincenzi, Canan G. Nebigil. Uncovering the role of prokineticin pathway on Epicardial Adipose Tissue (EAT) development and EAT-associated cardiomyopathy. Trends in Cardiovascular Medicine 2025; 35(5): 328 doi: 10.1016/j.tcm.2025.02.006
|
| 19 |
Aditi Singh, Sucharita Shadangi, Soumendra Rana. A rationally designed 18-amino acid peptide with potential as GLP-1 receptor agonist. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1789257
|
| 20 |
Julita Tokarek, Emilian Budny, Maciej Saar, Kamila Stańczak, Ewa Wojtanowska, Ewelina Młynarska, Jacek Rysz, Beata Franczyk. Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and Diabetes. Biomedicines 2023; 11(10): 2611 doi: 10.3390/biomedicines11102611
|
| 21 |
Eun Jeong Cho. Epicardial Adipose Tissue (Pericoronary Adipose Tissue) in Cardiovascular Diseases. International Journal of Heart Failure 2025; 7(4): 240 doi: 10.36628/ijhf.2025.0080
|
| 22 |
O. V. Tsygankova, N. E. Apartseva, L. D. Latyntseva, A. N. Ryabikov. Extended-release metformin in patients with prediabetes, chronic heart failure and abdominal obesity in light of the effect on fat depot compartments and glucose metabolism parameters. Diabetes mellitus 2024; 27(4): 357 doi: 10.14341/DM13189
|
| 23 |
O. V. Tsygankova, N. E. Apartseva, L. D. Latyntseva, A. N. Ryabikov, E. V. Kashtanova. Long-term effects of metformin on fat depots and insulin-glucose parameters in patients with prediabetes and chronic heart failure. Meditsinskiy sovet = Medical Council 2024; (16): 274 doi: 10.21518/ms2024-347
|